Technical Analysis for COR - Cencora, Inc.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| D | 224.60 | 0.23% | 0.51 |
COR closed up 0.23 percent on Friday, May 10, 2024, on 76 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Strong | Up | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| NR7 | Range Contraction | 0.00% | |
| NR7-2 | Range Contraction | 0.00% | |
| Narrow Range Bar | Range Contraction | 0.00% | |
| Oversold Stochastic | Weakness | 0.00% | |
| Non-ADX 1,2,3,4 Bearish | Bearish Swing Setup | 0.23% | |
| Calm After Storm | Range Contraction | 0.23% | |
| NR7 | Range Contraction | 0.23% | |
| Narrow Range Bar | Range Contraction | 0.23% | |
| Inside Day | Range Contraction | 0.23% | |
| Oversold Stochastic | Weakness | 0.23% |
| Alert | Time |
|---|---|
| Rose Above Previous Day's High | 3 days ago |
| Possible NR7 | 3 days ago |
| Possible Inside Day | 3 days ago |
| Lower Bollinger Band Support | 4 days ago |
| Outside Day | 5 days ago |
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 04/30/2024
Cencora is a leading global pharmaceutical solutions organization centered on improving the lives of people and animals around the world. We partner with pharmaceutical innovators across the value chain to facilitate and optimize market access to therapies. Care providers depend on us for the secure, reliable delivery of pharmaceuticals, healthcare products, and solutions. Our 46,000+ worldwide team members contribute to positive health outcomes through the power of our purpose: We are united in our responsibility to create healthier futures. Cencora is ranked #11 on the Fortune 500 and #24 on the Global Fortune 500 with more than $200 billion in annual revenue.
Sector: Healthcare
Industry: Medical Distribution
Keywords: Pharmaceutical Healthcare Products
Classification
Sector: Healthcare
Industry: Medical Distribution
Keywords: Pharmaceutical Healthcare Products
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 246.1885 |
| 52 Week Low | 161.8033 |
| Average Volume | 1,237,236 |
| 200-Day Moving Average | 207.85 |
| 50-Day Moving Average | 236.46 |
| 20-Day Moving Average | 232.58 |
| 10-Day Moving Average | 227.63 |
| Average True Range | 3.55 |
| RSI (14) | 33.77 |
| ADX | 29.98 |
| +DI | 13.16 |
| -DI | 27.90 |
| Chandelier Exit (Long, 3 ATRs) | 230.16 |
| Chandelier Exit (Short, 3 ATRs) | 232.34 |
| Upper Bollinger Bands | 245.71 |
| Lower Bollinger Band | 219.44 |
| Percent B (%b) | 0.2 |
| BandWidth | 11.29 |
| MACD Line | -3.78 |
| MACD Signal Line | -2.61 |
| MACD Histogram | -1.1648 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 227.08 | ||||
| Resistance 3 (R3) | 227.16 | 226.41 | 226.66 | ||
| Resistance 2 (R2) | 226.41 | 225.78 | 226.37 | 226.52 | |
| Resistance 1 (R1) | 225.51 | 225.39 | 225.96 | 225.43 | 226.39 |
| Pivot Point | 224.76 | 224.76 | 224.99 | 224.72 | 224.76 |
| Support 1 (S1) | 223.86 | 224.13 | 224.31 | 223.78 | 222.81 |
| Support 2 (S2) | 223.11 | 223.74 | 223.07 | 222.68 | |
| Support 3 (S3) | 222.21 | 223.11 | 222.54 | ||
| Support 4 (S4) | 222.13 |
